Burning Rock Biotech Limited American Depositary Shares (BNR) is a publicly traded Healthcare sector company. As of August 25, 2026, BNR trades at $9.43 with a market cap of $103.14M and a P/E ratio of 0.00. BNR moved +0.00% today. Year to date, BNR is -49.96%; over the trailing twelve months it is +4.67%. Its 52-week range spans $2.18 to $41.72. Analyst consensus is neutral with an average price target of $0.00. Rallies surfaces BNR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks the latest BNR news, catalysts, market updates, source links, and AI summaries when news is available.
| Metric | Value |
|---|---|
| Price | $9.43 |
| Market Cap | $103.14M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $41.72 |
| 52-Week Low | $2.18 |
| Volume | 8.28K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
1 analysts cover BNR: 0 strong buy, 0 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $0.00.